Login
$SEPN
$41.67 -$0.93 (2.18%) Live

Insider Transactions

What Septerna, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 15 40
Total trades 18 62

Shares traded

3 months 12 months
Acquired 25,833 328,314
Disposed 107,653 1,755,934
Net activity −81,820 −1,427,620

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Finer Jeffrey Chief Executive Officer Nov 12 Open-market sale · S −1,977 $46.16 −$91.3K 833,909
Finer Jeffrey Chief Executive Officer Nov 12 Open-market sale · S −2,823 $45.28 −$128K 835,886
Finer Jeffrey Chief Executive Officer Nov 12 Open-market sale · S −2,800 $44.23 −$124K 838,709
Finer Jeffrey Chief Executive Officer Nov 12 Open-market sale · S −5,300 $43.10 −$228K 841,509
Finer Jeffrey Chief Executive Officer Nov 12 Open-market sale · S −5,600 $42.09 −$236K 846,809
Finer Jeffrey Chief Executive Officer Nov 12 Exercise / conversion · M +18,500 $2.76 +$51.1K 852,409
Ezekowitz Alan Director Nov 11 Open-market sale · S −1,055 $51.90 −$54.8K 35,600
Ezekowitz Alan Director Nov 11 Open-market sale · S −2,013 $50.90 −$102K 36,655
Ezekowitz Alan Director Nov 11 Open-market sale · S −4,175 $49.65 −$207K 38,668
Ezekowitz Alan Director Nov 11 Open-market sale · S −31,572 $48.70 −$1.54M 42,843
Ezekowitz Alan Director Nov 11 Open-market sale · S −22,865 $47.78 −$1.09M 74,415
Ezekowitz Alan Director Nov 11 Open-market sale · S −13,201 $47.01 −$621K 97,280
Ezekowitz Alan Director Nov 11 Open-market sale · S −6,939 $46.01 −$319K 110,481
Bhatt Elizabeth President and COO Oct 15 Open-market sale · S −2,906 $37.61 −$109K 174,209
Bhatt Elizabeth President and COO Oct 15 Open-market sale · S −1,094 $36.87 −$40.3K 177,115
Bhatt Elizabeth President and COO Oct 15 Exercise / conversion · M +4,000 $6.81 +$27.2K 178,209
Long Daniel D. SVP, Drug Discovery Sep 01 Open-market sale · S −3,333 $37.83 −$126K 96,412
Long Daniel D. SVP, Drug Discovery Sep 01 Exercise / conversion · M +3,333 $2.76 +$9.2K 99,745
Third Rock Ventures V, L.p. 10% owner Aug 12 Open-market sale · S +141 $51.08 +$7.2K 6,068,391
Ra Capital MANAGEMENT, L.p. Director Aug 12 Open-market sale · S −746,500 $42.50 −$31.7M 725,443

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support